Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood

Fetal Diagnosis and Therapy

Volumn 35, Issue 3, 2014, Pages 212-217

  Nicolaides, Kypros H ^a   Syngelaki, Argyro ^a   Gil, Maria Del Mar ^a   Quezada, Maria Soledad ^a   Zinevich, Yana ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cell free DNA; Non invasive diagnosis; Prenatal diagnosis; Triploidy

Indexed keywords

CELL FREE DNA; GENOMIC DNA; UNCLASSIFIED DRUG; DNA;

ADULT; ARTICLE; BLOOD BUFFY COAT; BODY WEIGHT; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME NUMBER; CONTROLLED STUDY; DIANDRIC TRIPLOIDY; DIGYNIC TRIPLOIDY; DIZYGOTIC TWINS; DNA SEQUENCE; FEMALE; FETUS; GENE AMPLIFICATION; GENE DOSAGE; GENE FREQUENCY; GENETIC SCREENING; GESTATIONAL AGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MULTIPLEX POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLOIDY; TRISOMY; X CHROMOSOME; Y CHROMOSOME; CELL FREE SYSTEM; FETAL DISEASES; GENETICS; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PHYSIOLOGY; PREGNANCY; PROCEDURES; YOUNG ADULT;

ADULT; CELL-FREE SYSTEM; DNA; FEMALE; FETAL DISEASES; HUMANS; MALE; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; TRIPLOIDY; YOUNG ADULT;

EID: 84906886288     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000355655     Document Type: Article

References (27)

1. Jacobs PA, Angell RR, Buchanan IM, Hassold TJ, Matsuyama JS, Manuel B: The origin of human triploids. Ann Hum Genet 1978; 42: 49-57.
2. Snijders RJM, Sebire NJ, Nicolaides KH: Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995; 10:356-367.
3. McFadden DE, Kwong LC, Yam IYL, Lan-glois S: Parental origin of triploidy in human fetuses: evidence for genomic imprinting. Hum Genet 1993; 92:465-469.
4. Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH: Early prenatal diagnosis of trip-loidy. Am J Obstet Gynecol 1997; 176: 550-554.
5. Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH: Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000; 20:495-499.
6. Kagan KO, Anderson JM, Anwandter G, Nek-sasova K, Nicolaides KH: Screening for trip-loidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Prenat Diagn 2008; 28:1209-1213.
7. Rijhsinghani A, Yankowitz J, Strauss RA, Kuller JA, Patil S, Williamson RA: Risk of pre-eclampsia in second-trimester triploid pregnancies. Obstet Gynecol 1997; 90:884-888.
8. Seckl MJ, Sebire NJ, Berkowitz RS: Gestation-al trophoblastic disease. Lancet 2010; 376: 717-729.
9. Engelbrechtsen L, Brøndum-Nielsen K, Eke-lund C, Tabor A, Skibsted L: Detection of trip-loidy at 11-14 weeks of gestation: a cohort study of 198, 000 pregnant women. Ultrasound Obstet Gynecol 2013, E-pub ahead of print.
10. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13:913-920.
11. Bianchi DW, Platt LD, Goldberg JD, Abuha-mad AZ, Sehnert AJ, Rava RP: Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119:890-901.
12. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A: Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gy-necol 2012; 206:319.e1-e9.
13. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH: Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-e5.
14. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G: Noninvasive prenatal testing for fetal trisomies in a routinely screened firsttrimester population. Am J Obstet Gynecol 2012; 207:374.e1-e6.
15. Zimmermann B, Hill M, Gemelos G, Dem-ko Z, Banjevic M, Baner J, Ryan A, Sigur-jonsson S, Chopra N, Dodd M, Levy B, Rabinowitz M: Noninvasive prenatal aneu-ploidy testing of chromosomes 13, 18, 21, X, and Y using targeted sequencing of polymorphic loci. Prenat Diag 2012; 32:1233-1241.
16. Nicolaides KH, Syngelaki A, Gil M, Atanaso-va V, Markova D: Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013; 33:575-579.
17. Samango-Sprouse C, Banjevic M, Ryan A, Sigurjonsson S, Zimmermann B, Hill M, Hall MP, Westemeyer M, Saucier J, Demko Z, Rabinowitz M: SNP-based non-invasive prenatal testing detects sex chromosome aneu-ploidies with high accuracy. Prenat Diagn 2013; 33:643-649.
18. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translu-cency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A. Hum Re-prod 2008; 23:1968-1975.
19. Liao GJ, Chan KC, Jiang P, Sun H, Leung TY, Chiu RWK, Lo DYM: Non-invasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targets massively parallel sequencing of maternal plasma DNA. PLoS One 2012; 7:e38154.
20. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH: Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors. Fetal Diagn Ther 2012; 31:237-243.
21. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH: Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013; 41: 26-32.
22. Poon LC, Misci T, Song K, Syngelaki A, Nicolaides KH: Maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 2013; 33:215-223.
23. Haghiac M, Vora NL, Basu S, Johnson KL, Presley L, Bianchi DW, Mouzon SH: Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) 2012; 20:2213-2219.
24. Faas BH, de Ligt J, Janssen I, Eggink AJ, Wijn-berger LD, van Vugt JM, Vissers L, Geurts van Kessel A: Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel se-quencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012; 12(suppl 1):S19-S26.
25. Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH: Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013; 42:34-40.
26. Nicolaides KH, Wright D, Poon LC, Syngela-ki A, Gil MM: First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013; 42:41-50.
27. Nicolaides KH: Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29:183-196.